Magnesium Blood Pressure Meta-analysis: What the Evidence Says

Quick Answer

Magnesium Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Metabolic syndrome (MetS), also known as Syndrome X, is a major risk factor for cardiovascular disease worldwide. [Zhao Pengyu (2026); evidence level 1]
• MetS components typically include abdominal obesity, hypertension, dysregulated glucose metabolism, and dyslipidemia (elevated TG levels and reduced HDL-C levels). [Zhao Pengyu (2026); evidence level 1]
• Thus, this review aims to integrate advances in magnesium physiology with contemporary clinical and nutritional evidence, providing a consolidated strategy for understanding the causes, manifestations, diagnosis, and management of hypomagnesemia. [Papagiannidou Anastasia (2026); evidence level 3]
• Finally, we also cover practical laboratory assessment and evidence-informed repletion strategies. [Papagiannidou Anastasia (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For magnesium blood pressure meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Zhao Pengyu (2026). The effect of DASH diet on components of metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. DOI: 10.3389/fnut.2026.1738410. PMCID: PMC13199047. PMID: 42199758. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13199047/
• Papagiannidou Anastasia (2026). Hypomagnesemia: A Clinical and Nutritional Update. DOI: 10.1007/s13668-026-00745-5. PMCID: PMC13009017. PMID: 41872423. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13009017/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.